Dentis Co., Ltd. is a model medical company that develops medical LED and provides medical professional equipments and services based on excellent technology starting from dental implants in 2005. Dentis has received IR52 Jang Young Sil Award and Certifications from the Minister of Knowledge Economy in recognition for its relentless investments in R&D and innovative achievements of research in diverse areas of medicine. In 2013, Dentis is participating as the subject of national project for the development of transplantable medical devices by the Ministry of Knowledge Economy based on its biotechnology. Not only is Dentis establishing its position in South Korea but also in the global market through international sales, it is also entering a fair competition with the global companies through relentless challenges.
Unlock the market timeline & signal feed
New Product & Tech activity — 1 fresh signal just appeared.
The order this company entered each market — oldest to newest
Dentis Expands Southeast Asia Presence
Dentis Expands Southeast Asia Presence
Sign up to see the full signal feed
How Dentis's international expansion compares to its competitors
DentisYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 DentisYou | 2 | 2 | +100% | 3 | 54 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
20 technologies detected across the stack.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
4 mentions in the last 90 days.
Dentis expands in Vietnam and Thailand through local subsidiaries, conducting training seminars for 300 medical professionals and launching AXEL implant with December symposium planned.
Dentis issued 8 billion won in 4th convertible bonds to repay 3rd bond debt. Conversion price is 3,102 won per share, convertible to 2.58M shares (14% of total).
Dentis CEO Sim Gi-bong acquired 11,224 shares through on-market purchases, increasing his holdings to 4,341,391 shares (27.46% stake), up 0.08 percentage points from previous disclosure.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Dentis's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
